Stock Analysis

Exploring 3 Undiscovered Gems In Global Markets

TPEX:4728
Source: Shutterstock

As global markets show signs of easing trade tensions and small-cap equities continue their upward trend, investors are keenly observing the broader economic indicators that influence these segments. With U.S. business activity growth hitting a 16-month low and consumer sentiment declining, identifying stocks with strong fundamentals and resilience in uncertain conditions becomes increasingly important.

Top 10 Undiscovered Gems With Strong Fundamentals Globally

NameDebt To EquityRevenue GrowthEarnings GrowthHealth Rating
Brillian Network & Automation Integrated SystemNA21.03%21.51%★★★★★★
Woori Technology InvestmentNA19.59%-2.63%★★★★★★
Synmosa Biopharma30.18%16.26%21.16%★★★★★★
Shenzhen TVT Digital Technology2.68%10.54%29.43%★★★★★★
Grade Upon TechnologyNA10.27%66.81%★★★★★★
Fuling Technology12.25%15.82%20.63%★★★★★★
Zhejiang Chinastars New Materials Group38.79%0.20%4.21%★★★★★☆
Techshine ElectronicsLtd4.78%15.06%17.63%★★★★★☆
Time Interconnect Technology78.17%24.96%19.51%★★★★☆☆
Kwong Lung Enterprise38.83%-3.82%12.53%★★★★☆☆

Click here to see the full list of 3275 stocks from our Global Undiscovered Gems With Strong Fundamentals screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Alpha Group (SZSE:002292)

Simply Wall St Value Rating: ★★★★★★

Overview: Alpha Group is an animation and entertainment company with operations in China and internationally, holding a market cap of approximately CN¥13.20 billion.

Operations: Alpha Group generates revenue primarily from its Games & Toys segment, which contributes CN¥2.73 billion. The company's gross profit margin is 42.5%, reflecting the efficiency of its production and sales processes within this segment.

Alpha Group, a promising player in the market, has shown significant financial strength with a net debt to equity ratio at 2.9%, deemed satisfactory. The company’s interest payments are comfortably covered by EBIT at 8.7 times, indicating robust financial health. Over the past five years, Alpha Group has reduced its debt to equity ratio from 33.9% to 18.2%, reflecting prudent financial management and improved leverage position. Recently becoming profitable and boasting high-quality earnings, it stands out in its industry context despite not engaging in share repurchases this year under its announced buyback program of up to CNY 130 million.

SZSE:002292 Earnings and Revenue Growth as at May 2025
SZSE:002292 Earnings and Revenue Growth as at May 2025

Sunmax Biotechnology (TPEX:4728)

Simply Wall St Value Rating: ★★★★★★

Overview: Sunmax Biotechnology Co., Ltd. is a biomedical company that develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China with a market cap of NT$25.82 billion.

Operations: Sunmax generates revenue primarily from its Mainland China Operations Department, contributing NT$1.66 billion, and its Taiwan Operating Segment, adding NT$949.18 million. The company's financials reflect a net profit margin trend that provides insights into its profitability dynamics.

Sunmax Biotechnology, a small player in the biotech space, is showing promising signs of growth. Over the past five years, its earnings have surged by 35% annually. The company is debt-free and boasts high-quality non-cash earnings. Despite not outpacing industry growth last year with an 8.6% increase compared to the sector's 13.1%, Sunmax remains profitable with a solid cash runway. Recent financials highlight sales of TWD 1.82 billion and net income of TWD 679 million for the full year ending December 2024, reflecting steady progress from previous figures of TWD 1.69 billion and TWD 626 million respectively.

TPEX:4728 Earnings and Revenue Growth as at May 2025
TPEX:4728 Earnings and Revenue Growth as at May 2025

Nippon Densetsu Kogyo (TSE:1950)

Simply Wall St Value Rating: ★★★★★☆

Overview: Nippon Densetsu Kogyo Co., Ltd. specializes in railway electronics equipment construction in Japan, with a market cap of ¥127.59 billion.

Operations: The company generates revenue primarily from railway electronics equipment construction in Japan. It has a market capitalization of approximately ¥127.59 billion.

Nippon Densetsu Kogyo, a niche player in the construction industry, has been making waves with its strong financial footing and strategic initiatives. The company boasts a price-to-earnings ratio of 10.9x, undercutting the JP market average of 12.9x, which suggests potential value for investors. Its earnings surged by 31% last year, outpacing the broader industry's growth rate of 23%. Despite this robust performance, future earnings are expected to dip by an average of 7% annually over three years. Recently, it completed a share buyback worth ¥645 million for 300,000 shares to enhance shareholder value.

TSE:1950 Debt to Equity as at May 2025
TSE:1950 Debt to Equity as at May 2025

Summing It All Up

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About TPEX:4728

Sunmax Biotechnology

A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.

Flawless balance sheet with acceptable track record.